Immune checkpoint inhibitors may variably impact patients with pre-existing autoimmune diseases.
Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases / Meserve, J., Facciorusso, A., Holmer, A.K., Annese, V., Sandborn, W.J., Singh, S.. - In: ALIMENTARY PHARMACOLOGY & THERAPEUTICS. - ISSN 0269-2813. - 53:3(2021), pp. 374-382. [10.1111/apt.16217]
Systematic review with meta-analysis: safety and tolerability of immune checkpoint inhibitors in patients with pre-existing inflammatory bowel diseases
Annese, Vito;
2021-01-01
Abstract
Immune checkpoint inhibitors may variably impact patients with pre-existing autoimmune diseases.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
